Opening Keynote

Dr. Andrew Murray
Ping An Health Insurance Company of China,
COO / Head of Strategic Risk Management

MB ChB (Stellenbosch)

MBA (Duke)

Dr. Andrew Murray

Andrew is a medical doctor with a deep understanding of and extensive experience with the clinical practice and funding models of numerous healthcare markets. After gaining both clinical and management qualifications, Andrew joined Eli Lilly, a major multi-national pharmaceutical company, where he led the South African market access team. In this role he built relationships with many major health insurance and managed care organizations to ensure optimal coverage policies for Lilly’s products.

Andrew joined Discovery Health in 2006 as head of Discovery’s managed care unit where he played a leading role in developing key business strategies and managed the implementation thereof. As a senior business unit leader responsible for a large and highly specialized team, he focused on optimizing Discovery’s managed care processes, IT systems and the supporting organizational structures thereby yielding significant operational efficiencies over a three-year period of time. In additional to such traditional General Management functions, Andrew’s role further required of him to manage in real-time complex or conflicting clinical trade-offs, often requiring his personal intervention to broker optimal solutions that balance the interests of the Patient, the Funder and Providers.

In 2010, Andrew relocated to China to join the executive leadership team of Ping An Health (a health insurance JV between Discovery and the Ping An Group of China) as post-integration COO. After reaching key operational milestones and preparing the business for hand-over to local leadership, he executed a planned transition into a highly specialized, strategic role. In his new capacity as Head of Strategic Risk Management, Andrew is the senior executive primarily responsible for ensuring the ongoing profitability and sustainability of Ping An’s insurance business. The Ping An Health JV combines the respective strengths of each corporate parent, leveraging Discovery’s deep specialist health insurance expertise and Ping An’s formidable brand and distribution channels. Ping An Health holds one of only four, specialist health insurance licenses granted in the Chinese market.

Andrew is married to Nelie Murray – they live in Shanghai, China with their daughter, Rebekah, who was born in Shanghai.

Closing Keynote

James Hogan
Medtronic, President of Latin America

James Hogan

James Hogan is the President of Medtronic Latin America, an organization he has led since December 2007. In this role he has responsibilities for directing all sales, marketing, and medical support activities for the Cardiovascular, Cardiac Rhythm Disease Management, Spine, Diabetes, Neuromodulation and Surgical Technologies business units in Central America, South America, Puerto Rico and the Caribbean islands.

Prior to Medtronic, James held numerous senior executive roles in other Medical Device and Biotechnology Companies. After completing his undergraduate degree and MBA at the University of Minnesota, James worked for Pfizer’s medical device division for 13 years. Starting in Sales, he held various progressive sales and marketing positions, and finished his Pfizer career as Director of Sales and Marketing for Europe, the Middle East, and Africa. In 1995 James left Pfizer to start his own medical device company, and over the next 10 years started 3 separate medical device start-ups in the urology, vascular, and orthopedic fields, all of which were purchased by larger medical device companies. 

In 2005 James accepted the opportunity to manage the Medtronic Gastroenterology and Urology Division for Western Europe, based from the Medtronic International Headquarters in Tolochenaz, Switzerland.

James has had extensive international experience, having lived and worked in England, Switzerland, France, Israel, and Holland. He now resides in Miami, Florida with his wife and 3 children.

Panel 1: Pharmaceuticals & Devices

• Todd Schwarzinger, Morgan Stanley
• Sarah Moore, Johnson & Johnson - Ethicon Endosurgery 
• Adrienne Lovink, Millennium Research Group
• Gary Tyson, Pharma Initiatives Consulting Group
• Max Bikoff, Cardinal Health

Panel 2: Global Health

• Richard Bartlett, International Partnership for Innovative Healthcare Delivery
• Lauren Mikulski, Beckton Dickinson
• Gaile Renegar, GSK - Policy

Panel 3: Payer & Provider, Medical Tourism

• Sarah Downs, Price Waterhouse Coopers
• Bimal Shah, Duke Clinical Research Institute
• Hank Kearney, PHM International
• Lindsay Palazuelos, Partners in Health
• Egbe Osifo-Dawodu, Anadach Group